ArticleFrontiers in cardiovascular medicine2026
Chemogenetic activation of cholinergic intrinsic cardiac ganglia improves border zone oxygenation and reduces arrhythmias during acute local ischemia.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background: Current therapeutic strategies for acute myocardial infarction rely on reperfusion and pharmacological management, which are typically administered hours after an event. Activation of the cardiac cholinergic efferents superior to the heart soon after a coronary occlusion has shown promise as a potential therapy to reduce arrhythmias and improve ventricular function. We tested whether selective activation of cholinergic neurons within the intrinsic cardiac ganglia (ICG) would also reduce arrhythmias and improve oxygenation of ischemic border zone tissue after an acute coronary occlusion. Methods: Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) were selectively expressed in cholinergic neurons of the ICG via pericardial sac injections of an HM3Dq DREADDs virus in transgenic rats that expressed Cre recombinase in cholinergic neurons. Cholinergic ICG neurons were activated using the synthetic DREADDs ligand clozapine-N-oxide (CNO). Heart rate reductions after intraperitoneal injection of CNO confirmed downstream effect of DREADDs-mediated cholinergic ICG activation in ECG telemetry studies. The effect of cholinergic ICG activation on PR interval, arrhythmia burden, ischemic border zone tissue oxygenation and epicardial NADH fluorescence 20 min after ligation of the left anterior descending coronary artery (LAD) was then studied in excised perfused hearts of DREADDS-expressing rats and rats that did not receive the HM3Dq DREADDs virus. Results: LAD ligation resulted in a well defined ischemic zone that encompassed a large portion of the left ventricle, where pO2 in the center of the ischemic zone typically dropped to 0 mmHg within 10 s. Subsequent DREADDs-mediated cholinergic ICG activation prolonged the PR interval from 39.13 Conclusion: Results indicate that selective stimulation of cholinergic ICG neurons could improve local delivery of oxygen to the ischemic border zone soon after a coronary occlusion and reduce arrhythmia burden through a muscarinic-dependent mechanism, supporting further studies of the intrinsic cardiac cholinergic network as a therapeutic target for early intervention before reperfusion therapy to activate cardioprotective pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.